HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Add to Personal Folders Download to citation manager Permission Requests Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Bartkowski, R. Articles by Mrówczynski, W. Search for Related Content PubMed PubMed Citation Articles by Bartkowski, R. Articles by Mrówczynski, W. Related Collections Congenital - acyanotic Congenital - cyanotic

Eur J Cardiothorac Surg 2002;22:879-884
© 2002 Elsevier Science NL

Thyroid hormones levels in infants during and after cardiopulmonary bypass with ultrafiltration

R. Bartkowski^a*, M. Wojtalik^a, E. Korman^b, G. Sharma^a, J. Henschke^a, W. Mrówczyski^a

^a Department of Pediatric Cardiac Surgery, K. Marcinkowski University School of Medicine, ul. Fredry 10, 61-701 Poznan, Poland
^b Department of Pediatric Endocrinology and Diabetes, K. Marcinkowski University School of Medicine, ul. Fredry 10, 61-701 Poznan, Poland

Received 10 September 2001; received in revised form 5 September 2002; accepted 9 September 2002.

* Corresponding author. ul. Grunwaldzka 167A/29 60-323 Poznan, Poland. Tel.: +48-61-8600-235
e-mail: rbart{at}mp.pl

Objective: The aim of this study was to find out if infants after cardiopulmonary bypass develop non-thyroidal illness and if illness severity after cardiopulmonary bypass depends on hormone concentration in ultrafiltrate. Methods: Thyroid hormone status was assessed in 20 infants with congenital heart defects undergoing cardiac surgery (age range 7 days–11 months). Blood samples were collected preoperatively, during cardiopulmonary bypass, after cardiopulmonary bypass, and also postoperatively in 1, 2, 3, and 8 day after cardiac surgery. Plasma thyrotropin, thyroxine, free thyroxine, triiodothyronine, free triiodothyronine and reverse triiodothyronine were measured in blood samples and also in ultrafiltrate. Results: All patients had reduction in serum thyrotropin, thyroxine, free thyroxine, triiodothyronine, free triiodothyronine, and elevation of reverse triiodothyronine after cardiac surgery. In all patients we performed ultrafiltration. Patients were divided in to two groups. (with and without prolonged recovery). In the group of patients with prolonged recovery we noticed significantly higher amount of triiodothyronine per kilogram body weight. One of these patients died. The average level of total thyroxine decreased from the level 126 nmol/l before bypass to the minimal level 73 nmol/l after bypass, free thyroxine from the level 18 pmol/l before bypass to the minimal level 12 pmol/l after bypass. The average level of total triiodothyronine decreased from the level 1.54 nmol/l before bypass to the minimal level 0.42 nmol/l after bypass, free triiodothyronine from the level 6.12 pmol/l before bypass to the minimal level 3.21 pmol/l after bypass. The average level of TSH decreased from the level 4.31 mU/l before bypass to the level 0.64 mU/l after bypass. The average level of reverse-triiodothyronine increase from the level 0.83 nmol/l before bypass to the maximal level 1.94 nmol/l after bypass. Conclusions: We conclude that non-thyroidal illness occurs in all infants after cardiopulmonary bypass. The amount of free triiodothyronine that is filtrated during cardiopulmonary bypass may influence postoperative recovery.

Key Words: Thyroid hormone • Congenital • Cardiopulmonary bypass

This article has been cited by other articles:

				F. Merkle, W. Boettcher, F. Schulz, A. Koster, M. Huebler, and R. Hetzer Perfusion technique for nonhaemic cardiopulmonary bypass prime in neonates and infants under 6 kg body weight Perfusion, July 1, 2004; 19(4): 229 - 237. [Abstract] [PDF]